• Hemp industry lawsuit challenging DEA’s position on CBD picks up support of 28 U.S. legislators

    A bipartisan congressional coalition pushed back on the DEA's assertion that cannabidiol and extracts derived from hemp are Schedule I substances.

    Next on feeds.denverpost.com

    System evaluation: This is  truth  with an error of 50%

    User rating: This is  truth  with an error of 50%

    You can give your personal estimation of the news to underline their conformity to real facts. By voting, you teach the system to distinguish truth and false. Your input will help people get independent view on things happening.